Pierre Bédossa
0000-0002-8487-7322
Publication & Citation Trends
Publications
0 total
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study. OA
Cited by 124
Semantic Scholar
Practical diagnosis of cirrhosis by liver specialists in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
Cited by 0
Semantic Scholar
Evaluation of PXL065 - Deuterium-Stabilized (R)-Pioglitazone in NASH Patients: a Phase 2 randomized placebo-controlled trial (DESTINY-1).
Cited by 56
Semantic Scholar
Primary results from MAESTRO-NASH a pivotal phase 3 52-week serial liver biopsy study in 966 patients with NASH and fibrosis
Cited by 20
Semantic Scholar
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis OA
Cited by 8
Semantic Scholar
Prospective direct comparisons of four widespread non-invasive fibrosis tests (NITs) in outpatients with type-2 diabetes (T2D) using EPoS histological staging as reference
Cited by 0
Semantic Scholar
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study OA
Cited by 26
Semantic Scholar
Non-invasive tests of liver injury, inflammation and fibrosis are improved by efruxifermin and correlate with histological improvements in F2-F3 NASH patients: secondary analysis of Ph2b HARMONY study
Cited by 0
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(450)
Hepatitis C virus research
(152)
Hepatitis B Virus Studies
(98)
Liver Diseases and Immunity
(93)
Liver Disease and Transplantation
(83)
Affiliations
Université Paris-Sud
Hôpital Necker-Enfants Malades
Centre National de la Recherche Scientifique
Cliniques Universitaires Saint-Luc
San Francisco VA Medical Center